Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 22 No. 3 (2016)

Vol. 22 No. 3 (2016)

Published: 2016-12-28

Article

  • Business Model Innovation Opportunities for the Biopharmaceutical Industry: A Systematic Review

    James B. Downs, Vivek Velamuri
    • PDF
  • Bioinformatics Patents - The Challenges

    Rujita Ravindra Shenoy
    • Requires Subscription PDF (USD 25)
  • Prospects and Challenges for the Commercialization of Biosimilars: Perspectives from the EU, Japan, and the US

    Joanna Brougher
    • Requires Subscription PDF (USD 25)

From the Boardroom

  • Industry Partnerships, Key Success Factor to Win in the Biosimilars Space

    Catherine Godrecka-Bareau
    • Requires Subscription PDF (USD 25)
  • Biotechnology, a strategic planning orphan: towards an effective strategy framework for biotechnology firms

    Peter L Molloy, Lester W Johnson
    • Requires Subscription PDF (USD 25)

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust